Patents Assigned to Arevipharma GmbH
  • Patent number: 9040697
    Abstract: 4,6-dichloro-2-methyl-5-(1-acyl-2-imidazolin-2-yl)-aminopyrimidine is reacted with methanol in the presence of a non-ionic organic base, and moxonidine is obtained directly from the reaction mixture.
    Type: Grant
    Filed: February 5, 2014
    Date of Patent: May 26, 2015
    Assignee: AREVIPHARMA GmbH
    Inventors: Harald Hofmeier, Michael Limmert, Heike Heydemüller, Helge Hartenhauer
  • Publication number: 20130184471
    Abstract: The present invention relates to a process for preparing bendamustine hydrochloride, derivatives and related compounds thereof.
    Type: Application
    Filed: January 16, 2013
    Publication date: July 18, 2013
    Applicant: Arevipharma GmbH
    Inventor: Arevipharma GmbH